Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreo Medical Regulatory News (CREO)

Share Price Information for Creo Medical (CREO)

Share Price is delayed by 15 minutes
Get Live Data
13.50    0.00 (0.00%)
Bid:
13.25
Ask:
13.75
Spread: 0.50 (3.774%)
Market Cap: £65.58m
CREO Live PriceLast checked at - London Stock Exchange

Intraday Creo Medical Share Chart

Shareholder notification

26 Mar 2010 16:35

RNS Number : 2905J
China Real Estate Opportunities PLC
26 March 2010
 



China Real Estate Opportunities plc

 

Significant shareholder notification

 

In accordance with Rule 17 of the AIM Rules, China Real Estate Opportunities plc ("CREO" or the "Company") announces that on 26 March 2010 it was notified by a director and a significant shareholder of the following change in one of its significant shareholders.

 

On 22 March 2010, Treasury Holdings transferred its interests in Daylasin Limited to Richard Barrett, a director of the Company, and John Ronan, a significant shareholder in the Company. Mr Barrett and Mr. Ronan each hold 50 per cent of the shares in Treasury Holdings and, following this transaction, Daylasin Limited respectively.

 

Daylasin holds 5,345,819 ordinary shares of no par value in the Company, representing 11.13 per cent of the issued share capital of the Company. The price paid by Mr. Barrett and Mr. Ronan for their interests in Daylasin Limited equates to 348p for each share in the Company held by Daylasin Limited.

 

Following this transaction, Richard Barrett remains interested in 8,955,518 ordinary no par value shares representing 18.64 per cent of the issued share capital of the Company, John Ronan remains interested in 11,610,008 ordinary no par value shares representing 24.17 per cent of the issued share capital of the Company, and Treasury Holdings has no further interests in the Company.

 

Contact:

CREO

Ray Horney, Chairman

Tel: +44 (0) 1273 775 225

 

Sarah Moriarty, Investor Relations

Tel: + 353 1 618 9455

 

Matrix Corporate Capital LLP

Paul Fincham, Rob Naylor

Tel: +44 (0) 20 3206 7000

 

Davy

Des Carville

Tel: +353 1 679 6363

 

Citigate Dewe Rogerson Limited

Tom Baldock

Tel: +44 (0) 20 7638 9571

 

Murray Consultants

Ed Micheau

Tel: +353 1 498 0300

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSKKADNABKDNNB
Date   Source Headline
9th Dec 20207:00 amRNSFirst clinical use of new Creo GI product
24th Nov 20201:36 pmRNSExercise of Options
3rd Nov 20207:00 amRNSAcquisition of Boucart Medical SRL
2nd Nov 20207:00 amRNSUS FDA clearance for MicroBlate™ Fine device
23rd Sep 20207:00 amRNSHalf-year Report
26th Aug 20204:09 pmRNSHolding(s) in Company
11th Aug 20207:00 amRNSExercise of Options
3rd Aug 20207:00 amRNSVideo abstract published endorsing Speedboat
24th Jul 202011:00 amRNSDirector/PDMR Shareholding
24th Jul 20207:00 amRNSAcquisition of Albyn Medical S.L.
13th Jul 202010:37 amRNSSecretary of State for Wales site visit
13th Jul 202010:08 amRNSSecretary of State for Wales site visit
6th Jul 20207:00 amRNSDirectorate Change
2nd Jul 20207:00 amRNSDevelopment loan for plasma sterilising product
24th Jun 202010:30 amRNSResult of AGM
15th Jun 20207:00 amRNSCE mark for five new devices
8th Jun 20207:00 amRNSIET Prize nomination
3rd Jun 20207:00 amRNSPositive NHS health economics data
27th May 20207:00 amRNSPosting of Annual Report & Notice of AGM
20th May 20207:00 amRNSCommercialisation Agreement
7th May 20207:00 amRNSFinal Results
23rd Mar 20207:00 amRNSFDA Clearance for HS1 Haemostasis Device
20th Mar 20207:00 amRNSTrading update – COVID-19 impact
4th Mar 20205:00 pmRNSExercise of Options
24th Feb 20203:49 pmRNSHolding(s) in Company
19th Feb 20207:00 amRNSLTIP Awards and Issue of Equity
11th Feb 20207:00 amRNSVideo abstracts re. Speedboat procedures in India
7th Feb 202011:50 amRNSExercise of Options
6th Feb 20207:00 amRNSGrowth & Innovation Forum 2020
3rd Feb 20207:00 amRNSAppointment of NED
30th Jan 20207:00 amRNSTrading update
30th Dec 20193:17 pmRNSHolding(s) in Company
27th Dec 20195:00 pmRNSHolding(s) in Company
24th Dec 20198:01 amRNSDirector/PDMR Shareholding
23rd Dec 201911:15 amRNSResult of General Meeting and Total Voting Rights
23rd Dec 20197:00 amRNSResult of Open Offer
4th Dec 20197:00 amRNSRe. Placing, Open Offer, and Posting of Circular
2nd Dec 20197:00 amRNSFundraising and Launch of Accelerated Book Build
20th Nov 20197:00 amRNSFirst in-human cases in India
22nd Oct 20197:00 amRNSCommercial Launch of Speedboat at UEG Week
17th Oct 20197:00 amRNSUK Endoscopy Training Course
30th Sep 20197:00 amRNSHalf-year Report
26th Sep 20197:00 amRNSFramework Distribution Agreement for India
23rd Sep 20192:16 pmRNSNotice of Results
10th Sep 20197:00 amRNSUS Clinical Education Programme enters Phase II
7th Aug 20191:57 pmRNSDirector/PDMR Shareholding
5th Jul 20197:00 amRNSInstitute of Physics Award
25th Jun 20197:00 amRNSFirst commercial orders for Speedboat
6th Jun 20191:23 pmRNSResult of AGM
13th May 201910:50 amRNSAnnual Reports & Accounts & Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.